Richard Murray is the founder of Jounce Therapeutics. Jounce Therapeutics has raised $103M in total funding. Latest round: Series B.
Dr. Richard Murray is the CEO of Jounce Therapeutics, a Cambridge, Massachusetts-based biotech company focused on cancer immunotherapies. He joined Jounce in 2024 and previously served as an executive at Merck & Co. Murray has overseen significant funding milestones, including a $56 million Series B round for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library